| Jan N Dalby, NP | |
|
7113 Three Chopt Rd, Suite 101, Richmond, VA 23226-3643 | |
| (804) 282-4205 | |
| (804) 673-6432 |
| Full Name | Jan N Dalby |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 7113 Three Chopt Rd, Richmond, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023075553 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0017000950 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jan N Dalby, NP 7113 Three Chopt Rd, Suite 101, Richmond, VA 23226-3643 Ph: (804) 282-4205 | Jan N Dalby, NP 7113 Three Chopt Rd, Suite 101, Richmond, VA 23226-3643 Ph: (804) 282-4205 |
News Archive
The American College of Cardiology together with other North American cardiovascular societies has issued a framework for ethically and safely reintroducing invasive cardiovascular procedures and diagnostic tests after the initial peak of the COVID-19 pandemic.
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.
April 16 was a big day for Moderna, a Massachusetts biotech company on the verge of becoming a front-runner in the U.S. government's race for a coronavirus vaccine. It had received roughly half a billion dollars in federal funding to develop a COVID shot that might be used on millions of Americans.
An outbreak of coronavirus disease in a nursing home near Seattle is prompting urgent calls for precautionary tactics at America's elder care facilities, where residents are at heightened risk of serious complications from the illness because of the dual threat of age and close living conditions.
An emerging medical technology company focused on regenerative medicine, reports that the Company was granted European patent EP 1,452,141 entitled "Shock Wave Generating Device," which provides the Company exclusive rights in human and animal treatment devices that include the novel use of piezoelectric fibers to produce acoustic energy in the shock wave spectrum.
› Verified 7 days ago
Marieka Ann Helou, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 401 N 11th St, Nelson Clinic, 2nd Floor, Room 210, Richmond, VA 23298 Phone: 804-828-9300 | |
Rhoda B Mahoney, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7113 Three Chopt Rd, Suite 101, Richmond, VA 23226 Phone: 804-282-4205 Fax: 804-673-6432 | |
Dr. Tracy Stroma Mcneish, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9900 Independence Park Dr, Suite 100, Richmond, VA 23233 Phone: 804-747-1855 Fax: 804-762-8837 | |
Dr. Burak Gumuscu, MD, PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 5855 Bremo Road, Mob North,, Suite 703, Richmond, VA 23226 Phone: 804-281-8182 | |
Kathryn B Russell, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7113 Three Chopt Rd, Suite 101, Richmond, VA 23226 Phone: 804-282-4205 Fax: 804-673-6432 | |
Randall Wayne Johnson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7101 Jahnke Rd, 2nd Floor, Richmond, VA 23225 Phone: 804-323-8893 |